<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 His Excellency the President Lieutenant General Dr. Seretse Khama Ian 
 Khama of the Republic of Botswana, the Honorable Minister Dorcas Makgato 
 of the Ministry of Health and Wellness, the <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com%2Ffoundation%2FPages%2Fhome.aspx&amp;esheet=51512594&amp;newsitemid=20170221005215&amp;lan=en-US&amp;anchor=Bristol-Myers+Squibb+Foundation&amp;index=1&amp;md5=254d92e54f4be017a94d685f61e50edd" rel="nofollow" rel="nofollow">Bristol-Myers 
 Squibb Foundation</a>, Texas Children's Cancer and Hematology Centers 
 (TXCH) and Baylor College of Medicine International Pediatric AIDS 
 Initiative at Texas Children's Hospital (BIPAI) through public-private 
 partnerships with the governments of Botswana, Uganda and Malawi, 
 announced a $100 million initiative to create an innovative pediatric 
 hematology-oncology treatment network in southern and east Africa. The 
 comprehensive initiative called Global HOPE (Hematology-Oncology 
 Pediatric Excellence) will build long-term capacity to treat and 
 dramatically improve the prognosis of thousands of children with cancer 
 and blood disorders in southern and eastern Africa.
 
 
 In the United States, 80 percent of children with cancer survive. In 
 sub-Saharan Africa, the overwhelming majority of pediatric patients do 
 not survive. The mortality rate is estimated to be as high as 90 
 percent, meaning that thousands of children die from cancer across 
 Africa each year. This is in large part due to an inadequate healthcare 
 infrastructure and a significant lack of expert physicians and other 
 healthcare workers trained to treat children with cancer. The most 
 common types of childhood cancers are blood cancers, including leukemia 
 and lymphoma.
 
 
 Global HOPE will partner with local Governments and Ministries of Health 
 to build medical capacity to diagnose and treat pediatric blood 
 disorders and cancer in Botswana, Malawi and Uganda. The initiative will 
 also create significant clinical, educational and research capabilities. 
 Doctors, nurses and ancillary professionals will be recruited from 
 around the world to provide training to local healthcare professionals 
 and to begin treating children with blood disorders and cancer 
 immediately.
 
 
 "This project is building on a solid foundation for pediatric cancer 
 treatment in Botswana that began with pediatric oncologists from Texas 
 Children's Cancer and Hematology Centers," said His Excellency the 
 President Lieutenant General Dr. Seretse Khama Ian Khama of the Republic 
 of Botswana. "The Global HOPE program will bring to Botswana the latest 
 bio-medical technologies and the potential to work with local 
 institutions such as the Botswana Innovation Hub and University of 
 Botswana to quickly increase the survival of children with cancer and 
 life-threatening blood disorders in Botswana and the region."
 
 
 The Bristol-Myers Squibb Foundation is committing $50 million over five 
 years to fund the training of healthcare providers as well as clinical 
 infrastructure and operations. BIPAI will raise an additional $50 
 million for the initiative.
 
 
 "We are eager to get started on this critical initiative to help 
 children with blood disorders and cancer. Working with our partners and 
 drawing on our expertise of building sustainable health systems in 
 underserved countries, we will help make a significant difference in the 
 outcomes for children while creating a blueprint for other countries to 
 follow," said <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fbms.com%2Fourcompany%2Fleadership%2FPages%2Fgiovanni_caforio_bio.aspx&amp;esheet=51512594&amp;newsitemid=20170221005215&amp;lan=en-US&amp;anchor=Giovanni+Caforio%2C+M.D.&amp;index=2&amp;md5=40be9865d66f19beafb65a415ad6d71f" rel="nofollow" rel="nofollow">Giovanni 
 Caforio, M.D.</a>, chairman of the board of the Bristol-Myers Squibb 
 Foundation and chief executive officer, Bristol-Myers Squibb Company. 
 "This initiative builds on 18 years of success of the Foundation's <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fstf-pub.bms.com%2FPages%2FHome.aspx&amp;esheet=51512594&amp;newsitemid=20170221005215&amp;lan=en-US&amp;anchor=SECURE+THE+FUTURE%C2%AE&amp;index=3&amp;md5=251cda1b32361f37a6f5fa89be4f10a3" rel="nofollow" rel="nofollow">SECURE 
 THE FUTURE®</a> program and will offer new hope to 
 families impacted by pediatric blood disorders and cancer."
 
 
 As public-private partnerships, the various governments will each play 
 an important role in developing the pediatric hematology-oncology 
 network, assisting with the training, technical assistance, logistics 
 and resources to support Global HOPE.
 
 
 The Global HOPE initiative will train an estimated 4,800 healthcare 
 professionals from Botswana, Uganda, Malawi and other African countries, 
 including doctors and nurses specializing in pediatric 
 hematology-oncology and social workers. The program estimates that over 
 5,000 children will receive care in the first five years.
 
 
 "With only five pediatric oncologists currently in the countries of 
 Botswana, Malawi and Uganda combined, there are simply not enough expert 
 doctors to treat all the children diagnosed with blood disorders and 
 cancer. We believe in these countries there are more than 11,000 new 
 cases annually of pediatric cancer and 40,000 new cases of serious, 
 life-threatening blood disorders such as sickle cell disease and 
 hemophilia. Because of these staggering numbers, more healthcare 
 providers with special expertise are urgently needed," said David G. 
 Poplack, M.D., director of Texas Children's Cancer and Hematology 
 Centers and Professor of Pediatric Oncology at Baylor College of 
 Medicine. "Global HOPE will help build capacity in the region to 
 diagnose and care for children with blood disorders and cancer, offering 
 the potential for transformational change in survivorship for these 
 children."
 
 
 The Global HOPE initiative will be modeled on the work of the 
 Bristol-Myers Squibb Foundation, BIPAI and the Governments of Botswana, 
 Uganda and Malawi, which created the largest pediatric HIV treatment 
 network in the world, leveraging existing experience, infrastructure, 
 and public/private partnerships created through the initiative. Since 
 2003, the Bristol-Myers Squibb Foundation and BIPAI have trained 52,000 
 healthcare professionals and currently provide care for nearly 300,000 
 children with HIV and their families in sub-Saharan Africa, lowering the 
 mortality rate for these children to 1.2 percent.
 
 
 "The success we've had in radically changing the course of pediatric 
 HIV/AIDS in sub-Saharan Africa is due in large part to the tremendous 
 support provided by the country governments, healthcare providers on the 
 ground and donors who have made our work possible," said Mark W. Kline, 
 M.D., president and founder of BIPAI, physician-in-chief of Texas 
 Children's Hospital and chair of the Department of Pediatrics at Baylor 
 College of Medicine. "We look forward to helping patients and their 
 families by embarking on this unchartered area of cancer care in Africa. 
 Working with our partners, we aim to build a self-sustaining 
 infrastructure that changes the tide of these childhood diseases in 
 sub-Saharan Africa."
 
 
 About the Republic of Botswana and the Ministry of Health and Wellness
 
 
 Botswana is a country with two million inhabitants in southern Africa 
 with abundant and diverse natural resources. The official languages are 
 English and Setswana. Since independence in 1966, Botswana has been a 
 parliamentary republic; the chief of state and head of government is the 
 president. Botswana's economy is a success story in southern Africa due 
 to the investment of the government in the education, health, clean 
 water and telecommunications sectors to create a better standard of 
 living for its citizens and to foster a conducive environment for free 
 enterprise to prosper.
 
 
 The Ministry of Health and Wellness aims to improve the physical, 
 mental, and social well-being of every citizen of Botswana to fully 
 contribute to the development of Botswana through a healthy nation.
 
 
 About the Bristol-Myers Squibb Foundation
 
 
 The Bristol-Myers Squibb Foundation is committed to improving the health 
 outcomes of populations disproportionately affected by serious diseases 
 by strengthening healthcare worker capacity, integrating medical care 
 and community-based supportive services, and addressing unmet medical 
 need. The Foundation engages partners to develop, execute, evaluate and 
 promote innovative programs to help patients with lung cancer and 
 removing barriers to accessing care in the United States, HIV and 
 comorbid diseases such as cervical and breast cancers and tuberculosis 
 in sub-Saharan Africa, hepatitis B and C in China and India and 
 veterans' mental health and well-being in the U.S.
 
 
 Since 1999, the Bristol-Myers Squibb Foundation's SECURE THE FUTURE® 
 initiative has been working with partners in Africa to provide care and 
 support for communities affected by HIV, tuberculosis, women's cancer 
 and most recently, lung cancer. Global HOPE will apply this same 
 transformational model to pediatric oncology and hematology in a number 
 of the same geographic areas.
 
 
 Texas Children's Cancer and Hematology Centers at Texas Children's 
 Hospital
 
 
 Texas Children's Cancer and Hematology Centers (TXCH) is the largest 
 pediatric hematology-oncology program in the U.S., treating patients 
 from 35 states and 26 countries. TXCH performs advanced patient care, 
 cutting edge clinical and laboratory research and has largest training 
 program for pediatric hematology-oncology in the U.S. With a staff of 
 renowned experts, the centers have developed a wide array of programs 
 aimed at curing children with diagnoses ranging from the most common to 
 the very rare. The team of 186 faculty and nearly 1,000 staff have 
 pioneered many of the now standard treatments for pediatric cancer and 
 blood disorders. TXCH has a long-standing commitment to improving global 
 health. For more information, please visit <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Ftxch.org%2F&amp;esheet=51512594&amp;newsitemid=20170221005215&amp;lan=en-US&amp;anchor=txch.org&amp;index=4&amp;md5=884689ae10ef6485ff579c94bd55ae06" rel="nofollow" rel="nofollow">txch.org</a>.
 
 
 Baylor College of Medicine International Pediatric AIDS Initiative at 
 Texas Children's Hospital (BIPAI)
 
 
 Baylor International Pediatric AIDS Initiative (BIPAI) is a non-profit 
 organization dedicated to providing pediatric and maternal health care 
 in resource limited settings. BIPAI medical teams offer free medical 
 care and medical education for HIV/AIDS, tuberculosis, malaria, 
 malnutrition, obstetrics/gynecology, hematology/oncology and more. 
 Partnering with Texas Children's Hospital and Baylor College of 
 Medicine, BIPAI operates in 11 countries, caring for nearly 300,000 
 children and their families. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bipai.org&amp;esheet=51512594&amp;newsitemid=20170221005215&amp;lan=en-US&amp;anchor=www.bipai.org&amp;index=5&amp;md5=c8ddfc0fc8facbf08136fe5e20c6dcbd" rel="nofollow" rel="nofollow">www.bipai.org</a>.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170221005215r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170221005215/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170221005215/en/</a></body></html>

Press Releases

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa - Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa

ALVO

TEVA



SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva



SELARSDI is expected to be marketed in the U.S. on or

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)


Nativex, a leading digital marketing platform, has been awarded the &#34;2024 Trailblazer Award&#34; at the Baidu Ads Channel Ecosystem Core Agent Conference. The conference, themed &#34;Unite with AI, Win the

Nativex Honored with Baidu&#39;s 2024 Trailblazer Award for Helping Global Brands Expand into the Chinese Market


On Tap Credit Union is proud to announce President and CEO Tracie Wilcox has been named as a 2024 Colorado Titan 100 and GoWest Advocate of the Year. The Titan 100 program recognizes Colorado&#39;s Top 100 CEOs &amp;

On Tap Credit Union President and CEO Honored With Two Coveted Titles in 2024


The Board of Directors of Source Capital, Inc. (NYSE:SOR) (the &#34;Fund&#34;), approved maintaining the Fund&#39;s regular monthly distribution rate for each of the next three months as follows:


Regular Monthly

Source Capital, Inc. Declares Monthly Distributions on Common Stock


A gathering of influencers, luminaries and thought leaders convened at the &#34;Sonic Desert&#34; party at Coachella this past weekend. Alongside the festivities, attendees were given a glimpse of the future of zero emission

EIN and the DriveH2 Movement Shine Brightly at This Year&#39;s &#39;Sonic Desert&#39; Party at Coachella


Eversource Energy will webcast a conference call with financial analysts on Thursday, May 2, 2024, beginning at 9 a.m. Eastern Time, at which senior management will review the company&#39;s financial performance through the

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa